Cizzle Biotechnology Holdings Plc is a holding company, which engages in detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker. The firm is focused on early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker. CIZ1B is a variant of CIZ1, a naturally occurring cell nuclear protein involved in protecting deoxyribonucleic acid (DNA). Its CIZ1B biomarker detects lung cancer at its earliest and most treatable stage. The company is designed as a simple blood test, which enables early diagnosis before symptoms appear-when treatment options can transform outcomes for patients and families.
Follow-Up Questions
CIZZF 주식의 가격 성능은 어떻습니까?
CIZZF의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
Cizzle Biotechnology Holdings PLC의 주요 사업 주제나 업종은 무엇입니까?
Cizzle Biotechnology Holdings PLC은 Biotechnology 업종에 속하며, 해당 부문은 Health Care입니다
Cizzle Biotechnology Holdings PLC의 시가총액은 얼마입니까?
Cizzle Biotechnology Holdings PLC의 현재 시가총액은 $NaN입니다
